Q4 earnings were marginally ahead of consensus, the quality of delivery is low. Altria’s Q4 US combustible volume decline of 8.8% was slightly better, but a further acceleration in discount share and ...

Citi analyst Simon Hales maintained a Hold rating on Altria Group (MO – Research Report) today and set a price target of $52.00.Invest with ...

The cigarette giant beat expectations for the fourth quarter by a slender margin, but saw growth in its smoke-free product segments.

The main reason Altria stock pulled back was its guidance came up short. Management said adjusted earnings per share would grow 2% to 5%, reaching $5.22 to $5.37, which compares to the analyst ...

Altria exited that stake in 2023. Altria Group Inc.'s stock fell Thursday after the tobacco giant said it continues to face the challenge of counterfeit products in the rapidly growing vape market.

Altria Group reported a double beat in Q4, driven by strong growth from its on! brand. Read more to see why I remain bullish ...

Marlboro maker Altria said on Thursday its annual adjusted profit could be lower than estimated, citing rising competition ...

Altria's Q4 earnings matched expectations, with a $1 billion share buyback authorized and strong sales growth, while projecting modest 2025 EPS growth of 2-5%.

Altria remains positioned to generate $8.3 billion in attributable cash flow, likely sustaining a highly attractive ~10% ...

There are 2,838 funds or institutions reporting positions in Altria Group. This is an increase of 104 owner(s) or 3.80% in the last quarter. Average portfolio weight of all funds dedicated to MO ...

Altria Group Inc along with its subsidiaries is engaged in the manufacture and sale of cigarettes, machine-made large cigars, pipe tobacco, smokeless tobacco products and wine.

The decision by US District Judge Dabney Friedrich clears a hurdle for MSN to introduce the first US generic version of Switzerland-based Novartis' best-selling drug, which brought the company ...